Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Gallagher

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Medicina Oral, Patologia Oral Y Cirugia Bucal|April 3, 2022
Clinical manifestations of head and neck cancer in pediatric patients, an analysis of 253 cases in a single Brazilian centerL-P-A Arboleda, M-E Pérez-de-Oliveira, I-L Hoffmann, et al.
Circulation|January 1, 1990
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte functionP J Simpson, R F Todd, J K Mickelson, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2000
The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosisT B McClanahan, G W Hicks, D P Ignasiak, et al.
Journal of Thrombosis and Thrombolysis|March 15, 2001
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatranL Chi, T E Mertz, K L Rogers, et al.
Blood|December 9, 2000
Spontaneous thrombosis in mice carrying the factor V Leiden mutationJ Cui, D T Eitzman, R J Westrick, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Medicina Oral, Patologia Oral Y Cirugia Bucal|April 3, 2022
Clinical manifestations of head and neck cancer in pediatric patients, an analysis of 253 cases in a single Brazilian centerL-P-A Arboleda, M-E Pérez-de-Oliveira, I-L Hoffmann, et al.
Circulation|January 1, 1990
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte functionP J Simpson, R F Todd, J K Mickelson, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2000
The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosisT B McClanahan, G W Hicks, D P Ignasiak, et al.
Journal of Thrombosis and Thrombolysis|March 15, 2001
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatranL Chi, T E Mertz, K L Rogers, et al.
Blood|December 9, 2000
Spontaneous thrombosis in mice carrying the factor V Leiden mutationJ Cui, D T Eitzman, R J Westrick, et al.
Pageof 12